Results 141 to 150 of about 50,222 (210)

Topical Mitomycin C Application Following Surgical Excision in Canine Oral Papilloma: A Case Report. [PDF]

Vet Med Sci
Yong J, Kwon M, Yoon H, Lee S, Park KM.
europepmc   +1 more source

Comparison of Intravesical Bacillus Calmette-Guérin (BCG) and Mitomycin C for the Treatment of Non-Muscle-Invasive Bladder Cancer. [PDF]

Cureus
Shah KA, Shah SR, Khan WA, Nisar S, Zaidi SF, Asif M, Gul F, Ullah F.   +7 more
europepmc   +1 more source

The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors. [PDF]

Int J Pharm X
Salahi M, Varshosaz J, Rostami M, Esfahani SN, Hekmat A, Jahanian-Najafaabadi A, Minayian M.   +6 more
europepmc   +1 more source

Covalently Immobilized Mitomycin C on Polypropylene Sutures Creates a Non-Releasing Bioactive Interface That Modulates Vascular Smooth Muscle Cell Fate and Prevents Intimal Hyperplasia. [PDF]

Int J Mol Sci
Huang TY, Chiu WC, Chen KS, Liang YJ, Chen PY, Wang YC, Lin FH.   +6 more
europepmc   +1 more source

Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer. [PDF]

Ann Surg Oncol
Andersson Y, Løvstakken E, Herud TM, Waagene S, Flatmark K, Fleten KG.   +5 more
europepmc   +1 more source

Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. [PDF]

Cancers (Basel)
Oppelt P, Ley J, Auberle C, Knapp B, Zaretsky J, Wan F, Adkins D.   +6 more
europepmc   +1 more source

Three-year outcomes of two-stage intra-Tenon low-dose mitomycin C injection versus sponge application in trabeculectomy. [PDF]

BMJ Open Ophthalmol
Shih EJ, Chen YY.
europepmc   +1 more source

Inhibiting Postoperative Fibrosis in Glaucoma Filtration Surgery Through Porous PLLA/RGD Membrane Mediated Local/Sustained Delivery of Mitomycin C. [PDF]

Transl Vis Sci Technol
Wu X, Wu K, Ni S, Song S, Jia D, Tang J, Ran J, Liang L.   +7 more
europepmc   +1 more source

Use of Mitomycin C in Ophthalmic Surgery. [PDF]

J Curr Ophthalmol
Nassiri N, Sheibani K, Kavousnezhad S, Nassiri S, Azemati A, Nassiri N.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

EpiLASIK with Mitomycin C

European Journal of Ophthalmology, 2010
Purpose Mitomycin C after photorefractive keratectomy (PRK) is used to reduce the development of haze and regression in higher intended corrections. The aim of this study was to investigate the safety, stability, and efficacy of EpiLASIK with mitomycin C.
Christoph, Winkler von Mohrenfels, Ramin, Khoramnia, Mathias, Maier, Chris P, Lohmann   +3 more
openaire   +2 more sources